Modeling the Total Economic Value of Novel Type 1 Diabetes Therapeutic Concepts
New study from JDRF T1D Fund and JDRF shows the market for novel therapies for T1D is vastly understated for a disease that affects 18M globally and has no approved disease modifying therapy.